Exploiting MET dysregulation in EGFR-addicted non-small-cell lung carcinoma: a further step toward personalized medicine

Lignende værker

• Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
  af: Ferrara, Miriam Grazia, et al.
  Udgivet: (2020)
• Exploring the molecular and biological background of lung neuroendocrine tumours
  af: Simbolo, Michele, et al.
  Udgivet: (2019)
• Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
  af: Carbone, Carmine, et al.
  Udgivet: (2019)
• Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
  af: Di Noia, Vincenzo, et al.
  Udgivet: (2020)
• MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy
  af: Pilotto, Sara, et al.
  Udgivet: (2017)